Houston, Texas — According to state and local economic development sources Octapharma Plasma plans to invest $950,000.00 to build out 13,708 square feet of new space in Houston. The company plans to occupy the new space at 10945 FM 1960 West in Houston, on or about November 1, 2021. According to the company website Octapharma Plasma, Inc. is a U.S.-based company that collects, tests, and supplies human blood plasma used in the creation of medicines that treat millions of patients each year. We operate 80+ plasma donation centers and employ more than 3,500 staff nationwide. Our mission is to ensure a positive, safe customer experience for valued donors while producing a steady supply of quality plasma for therapies that improve the health and lives of patients worldwide. Octapharma Plasma, Inc. is a subsidiary of Octapharma AG. Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world.

To learn more about Octapharma Plasma, visit http://octapharmaplasma.com/

Company Contact:
Judy Smith, Chief Operating Officer
judy.smith@octapharmaplasma.com
704-654-4600

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved